Environmental and Molecular Mutagenesis - Legacy Tobacco ...
Environmental and Molecular Mutagenesis - Legacy Tobacco ...
Environmental and Molecular Mutagenesis - Legacy Tobacco ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
164 1989 EMS Abstracts<br />
~ Notes<br />
http://legacy.library.ucsf.edu/tid/clb93d00/pdf<br />
~<br />
to aromatic amines <strong>and</strong> 30 controls were exaeined .The clastogenic studies were carried '<br />
out vith micronucleus test on exfoliated cells from the urinary bladder <strong>and</strong> the careinQ<br />
genicity was evaluated through the cytopathological analysis of these cells . Urinary<br />
bladder cells were recovered by centrifuging the urine <strong>and</strong> pipetting the asdiASnted eelis<br />
onto microscopic slides .Air-dried-alides were Giemsa-atained to micronuclei analysis <strong>and</strong><br />
Papanicolau-stained to cytopathological analysis .Tbe possible correlation between preneoplasic<br />
cells <strong>and</strong> the frequency of micronuclei is being evaluated,whereas the possible<br />
effects of age,smoking habits,alcobol <strong>and</strong> coffee drinking are also discussed .The aim of<br />
the study presented here was to verify if a combined application of the micrawleus test<br />
<strong>and</strong> the cytopathological analysis in exfoliated urothelial cells could be used to identify<br />
population groups of high risk for urinary bladder cancer <strong>and</strong> to verify the antiinitagenic<br />
<strong>and</strong> anticarcinogenic 3-carotene supplementation effeet .The potential for this method<br />
to be used for noninvasive monitoring will be discussed .This work was supported by<br />
FINEP, CNPq <strong>and</strong> ROCHE .<br />
476<br />
CHROMOSOME CHANGES DURING NEOPLASTIC PROGRESSION IN RAT TRACHEAL EPITHELIAL (RTE)<br />
CELLS . K . Rithidech, D . G . Thomassen, <strong>and</strong> A . L . Brooks, Lovelace Inhalation<br />
Toxicology Research Institute, P .O . Box 5890, Albuquerque, New Mexico 87185 .<br />
Chromosome abnormalities are usually observed in tumor cells . Since it is not<br />
known if these abnormalities are the cause or consequence of tumor development, it is<br />
important to characterize chromosomal changes at all stages of progression . The<br />
purpose of this study was to analyze chromosomal changes in RTE cells at preneoplastic<br />
<strong>and</strong> neoplastic stages of tumorigenesis . RTE cells were exposed to 6 Gy of X-rays or<br />
N-methyl-N-nitro-N-nitrosoguanidine (MiNG) . Preneoplastic enhanced growth variants<br />
(EGVs), the first recognizable step in tumor progression of RTE cells to neoplasia,<br />
were isolated using a selective medium . Eighteen EGVs were isolated 35 days after<br />
exposure . All EGVa from passage 6 were evaluated for chromosomal changes <strong>and</strong> were<br />
injected into nude mice to test for their tumoriganicity . Five X-ray-induced ECVs<br />
have been analyzed . Four of the five cell lines were hyparploid <strong>and</strong> one was<br />
hypoploid . G-b<strong>and</strong>ing revealed unique chrosasomal alterations in each EGV . The<br />
specific type of changes were deletions (1q), isochromosomes (9q), translocations<br />
(5 . 12), marker chromosome/, <strong>and</strong> double minutes . Nost of the hyperploid EGVs possessed<br />
at least one extra copy of chromosome 1 . These results suggest that specific<br />
chromosomal changes can be detected in early stages of carcinogenesis . Cytogenetic<br />
studies of the remaining EGVs <strong>and</strong> of tumor cells produced in nude mice by these EGVs<br />
are underway . Results from these studies will help determine the role of chromosomal<br />
changet in tumor progression . (Research sponsored by the U .S . Department of Energy's<br />
Office of Health <strong>and</strong> <strong>Environmental</strong> Research under Contract No . DE-AC04-76EV01013 .)<br />
477<br />
CTTOGENETIC EVALUATION 0F THE IN VIVO GENOTOXICITT OF SUPERLBTNAL DOSES OF DIOXIN .<br />
S .D . Robertson <strong>and</strong> A .F . McFee, Oak Ridge Associated Universities, Oak Ridge, TN (USA) .<br />
The halogenated aromatic hydrocarbon, 2,3,7,8-tetrachlorodibanso-p-dioxin has<br />
received considerable attention as a highly toxic environmental pollutant . It !s a<br />
positive carcinogen in some test systems <strong>and</strong> a potent teratogen . Cytogenetic findings<br />
following various sub-lethal doses have ranged from no observable effect on either<br />
chromosome aberration or SCE induetion to modest but significant ineresses in the<br />
ineidence of aberrations . We administered single intraparitoneal lnjeetions of 250,<br />
500 <strong>and</strong> 1,000 ug/kg (lOx the acute lethal dose) to ule B6C3F1 mice <strong>and</strong> scored<br />
chromosome aberrations in marrow cells of 8 aice/treatment 17 hr later, <strong>and</strong> sister<br />
chromatid exchanges in 4 mice at 23 hr post-treataent . One-tail trend test analyses<br />
of the data indicated no significant change in the level of SCEs= the percent of calls<br />
containing aberrations was significantly incraased by the two lower doses but not the<br />
highest level . Sfnce dioxin is slowly excreted froa liver <strong>and</strong> fatty tissue storage<br />
<strong>and</strong> lethality of even very high dosas fs not expressed for about 2 weeks, !t was<br />
meaningful to study longer treatment-to-evaluation times . SCgs among 5 mice per group<br />
showed a significant lncruse (p< .05, t test) at 8 days after 1,000 vg/kg doses, but<br />
not at 2 or 4 days ; however, a repeat trial found no elevation of SCBs at 2, 4, 6, or<br />
8 days . The proportions of polycbro .atic erythrocytes baaring ∎icronucla! in the<br />
marrow of treated ∎ice were not different from controls at 1, 3, or 8 days, but<br />
micronuclei in peripheral blood erythroeytes were elevated at 3 days . We conclude<br />
that significant increases in cytogenetlc lesions are not consistently produced by<br />
superlethal doses of dioxin . Supported by NIRRS Interagency Agreement T01-ES-20100<br />
<strong>and</strong> DOE/ORAU Contract DE-AC05-760R00033 .<br />
~<br />
m<br />
CO<br />
Oh<br />
%O<br />
W MJ<br />
CO